Transcripta Bio

📍 Palo Alto, United States🗓 Founded 2020👥 24 employees
Biotechnology🌐 transcriptabio.com
Website LinkedIn
We are focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel. With data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies. Our Drug-Gene Atlas maps molecular structure and drug action to the whole cell transcriptome, revealing therapeutic candidates that rebalance gene expression to treat disease. Our proprietary artificial intelligence modeling suite, Conductor AI, used our Drug-Gene Atlas to discover and predict the effects of new drugs at transcriptome scale.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Transcripta Bio founded?
Transcripta Bio was founded in 2020.
What industry is Transcripta Bio in?
Transcripta Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Transcripta Bio based?
Transcripta Bio is headquartered in Palo Alto, United States.